Condition
Cutaneous Sarcoidosis
Total Trials
6
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
P 1 (1)
P 2 (5)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06978725Phase 2RecruitingPrimary
A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)
NCT05458492Phase 2Not Yet Recruiting
Sirolimus in Cutaneous Sarcoidosis
NCT00731757Phase 2Withdrawn
Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis
NCT03910543Phase 1CompletedPrimary
Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare
NCT02348905Phase 2Unknown
ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial
NCT00794274Phase 2Completed
The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis
Showing all 6 trials